Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia

BACKGROUND: After the approval of dutastride for androgenic alopecia (AGA) in 2009, Korean authority required a post-marketing surveillance to obtain further data on its safety profile. OBJECTIVE: The objective was to monitor adverse events (AEs) of dutasteride 0.5 mg in Korean AGA male patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Gwang Seong, Kim, Joon Hyung, Oh, Shin-Young, Park, Jung-Min, Hong, Ji-Soo, Lee, Yil-Seob, Lee, Won-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473/
https://www.ncbi.nlm.nih.gov/pubmed/27489426
http://dx.doi.org/10.5021/ad.2016.28.4.444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969473/
https://www.ncbi.nlm.nih.gov/pubmed/27489426
http://dx.doi.org/10.5021/ad.2016.28.4.444

Ejemplares similares